Blue Chip Partners, Inc. Vertex Pharmaceuticals Inc Transaction History
Blue Chip Partners, Inc.
- $1.26 Billion
- Q3 2025
A detailed history of Blue Chip Partners, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Blue Chip Partners, Inc. holds 1,375 shares of VRTX stock, worth $596,777. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,375
Previous 1,106
24.32%
Holding current value
$596,777
Previous $492,000
9.35%
% of portfolio
0.04%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,786Shares Held
231MCall Options Held
1.83MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...